Most Recent Articles by Britt Gambino
Patients with multiple sclerosis who experience severe fatigue should be screened for obstructive sleep apnea.
The Penumbra 3D revascularization device was recalled by the FDA because of a risk of the delivery wire breaking during use.
Shorter sleep duration may increase mortality risks associated with both cardiovascular and cerebrovascular disease.
Mortality among women with preeclampsia and pregnancy-associated stroke was significantly higher than in controls.
Higher glucose levels reduce likelihood of good outcome among stroke patients with good collaterals.
More Articles by Britt Gambino
Neurology Advisor Articles
- Increased Epilepsy Risk Identified in Multiple Sclerosis
- Distinct Clinical Characteristics Associated With Subarachnoid Hemorrhage
- Managing Chronic Pain Associated With Traumatic Brain Injury
- Magnesium Plus Environmental Enrichment Boosts Cognition, Memory in Alzheimer's Mouse Model
- Prognostic Significance of Weight Loss in Patients With Early Parkinsonism
- Coffee Consumption May Decrease Stroke Risk
- When and How to Approach Driving Cessation in Patients With Dementia
- NBT System Gets FDA Clearance for Depression Treatment
- Erenumab, Fremanezumab Reduce Migraine Frequency, Burden
- Some Antiepileptic Drugs Associated With Increased Risk for Toxic Epidermal Necrolysis
- McDonald Criteria Update: Further Distinction Between Relapsing-Remitting, Primary-Progressive MS
- Initial Treatment With Ethosuximide Improves Behavioral Outcomes in Childhood Absence Epilepsy
- Bevacizumab Wins Full FDA Approval for Glioblastoma Treatment
- Men With Parkinson Disease More Likely to Have Caregiver
- Diet Linked to Multiple Sclerosis Disability, Disease Severity